with clinical course to clarify the biological behavior of central neurocytoma.
Immunoreactivity to PCNA was investigated using monoclonal antibody and the avidin-biotin complex method. Each case was quantified using light microscopy and manual counting of positive nuclei. At least five high-power fields (ϫ 400) were examined. For AgNORs staining, 5-m-thick tissue sections were cut from the routinely processed paraffin blocks. These were dewaxed in xylene for 3 to 5 minutes, then rehydrated in a graded ethanol series and distilled water. The AgNORs staining solution was prepared by dissolving felatin in 1% aqueous formic acid at a concentration of 2%, then mixing these solutions in a 1:2 ratio. This mixture was immediately poured over the tissue sections, which were left for 60 minutes at 20˚C. The silver solution was washed with distilled water and the sections were dehydrated in a graded ethanol series to xylene and mounted in medium. For counting of the AgNORs in all specimens, 100 cells from each case were examined using a ϫ 100 oil-immersion objective lens to a total magnification of ϫ 1000. The tumor cells were taken at random and the numbers of AgNOR dots per cell were counted.
For DNA flow cytometry, 20-m tissue sections were dewaxed in xylene and treated with trypsin for single-cell suspension. The isolation medium was Dulbecco's phosphate-buffered saline containing 0.6% NP-40, 50 g propidium iodide per milliliter, and 2 g RNase per milliliter. The stained nuclei were then analyzed for their DNA content with a flow cytometer. A DNA histogram was generated by counting at least 50,000 nuclei. The proliferative index was defined as the sum of the activities of the S-and G 2 phase.
Results

Clinical Data
The age of the patients at diagnosis ranged from 15 to 60 years (mean 31.2 years) and the male/female ratio was 10:3. Most of the patients were young adults but there were two men who were 60 years old. The main clinical presentations were the symptoms related to raised intracranial pressure. Hemiparesis and decreased visual acuity were present in two patients. The duration of symptoms before diagnosis ranged from 5 days to 1 year (mean 3.9 months). One patient (Case 1) was lost to follow-up review after recurrence, and another patient (Case 10) died due to a recurrence of disease. The median followup period for the remaining 11 cases was 50 months and ranged from 14 to 109 months. All patients were followed postoperatively with computerized tomography (CT) or magnetic resonance (MR) imaging obtained twice a year during the first 2 years, annually for the next 2 years, then biennially. The result of treatment was assessed with the last follow-up image.
Diagnostic Studies
Eleven patients underwent CT scanning. These studies revealed that the tumors in 10 of the patients were round, relatively well circumscribed, and iso-or slightly hyperdense in the supratentorial intraventricular area. Cystic changes were present in eight cases and calcifications were found in seven. Images obtained using contrast materials showed relatively homogeneous enhancement in all cases. An MR image was obtained in 10 cases. The mass showed iso-to high signal intensity on T 1 -and T 2 -weighted images. All cases revealed moderate to strong enhancement with gadolinium-diethylenetriamine pentaacetic acid. The tumor was confined to the lateral ventricle in six cases and located in the lateral with extension into the third ventricle through the foramen of Monro in six cases. In one patient, the tumor seemed to extend from the posterior thalamus to the body and trigone area of the lateral ventricle (Case 10, Fig. 1 ). Cerebral angiography was performed in 12 cases. In 10 patients the tumor showed homogeneous vascular staining. Clinical and radiological findings are summarized in Table 1 .
Surgical Treatment
Fourteen surgical procedures were performed in the 13 patients. One patient (Case 6) underwent a second operation after partial resection of his tumor at another hospital. The approaches were: anterior transcallosal in eight cases, frontal transcortical in three, posteroparietal transcortical in one, frontal plus posteroparietal transcortical in one, and anterior transcallosal plus frontal transcortical in one. During each operation, demarcation of the mass was relatively sharp except in the area of attachment, which may have been the origin of the tumor. The attachment sites of the tumors were the septum pellucidum in nine cases, the lateral wall of the lateral ventricle in two, and the roof of the lateral ventricle in one. In one case, extension into the lateral ventricle from the posterior thalamus was confirmed intraoperatively (Case 10). Gross-total removal of the tumor was possible in six and subtotal removal was performed in seven cases. Profuse intraoperative bleeding was the main cause of subtotal removal in four patients. Postoperative radiation therapy had been administered in eight cases but no specific protocol was listed; three patients who underwent gross-total removal and five who underwent subtotal removal also received fractionated radiation therapy. No patient received adjuvant chemotherapy.
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Tumor Pathology
Light Microscopic Findings. All tumors except one exhibited essentially the same features, which are characteristic of these lesions: sheets of monotonous small-to medium-sized neoplastic cells with uniform round-to-oval nuclei and inconspicuous nucleoli. The chromatin pattern was vesicular. The cytoplasm was clear or eosinophilic. Some of the cells showed a "sunny side up" egglike appearance resembling that of the oligodendroglioma. The cytoplasmic border was indistinct. Capillary networks were well developed and divided the tumor cells into groups. A pericapillary acellular zone was seen in some cases mimicking the perivascular pseudorosettes of the ependymoma. Some cases showed coagulation-type necrosis. One case showed mild nuclear pleomorphism and mitoses (Case 8).
Immunohistochemical Analysis. In all 13 cases, NSE was strongly positive and showed a diffuse granular pattern. Synaptophysin was positive in 10 cases tested. Glial fibrillary acidic protein (GFAP) was positive in a few cells within the tumor mass; because they had dendritic processes and resembled astrocytes, they were thought to be entrapped nonneoplastic astrocytes (Table 2) . * Abbreviations: bilat = bilateral lateral ventricle; CE = contrast enhancement; high = high signal intensity; hyper = hyperdensity; ICP = intracranial pressure; III = third ventricle; iso = isodensity or isointensity; lat = lateral ventricle; low = low signal intensity; NP = study not performed; T 1 = T 1 -weighted; T 2 = T 2 -weighted; vis disturb = visual disturbance; Ϫ = feature absent; ϩ = feature present; ϩϩ = feature marked; ϩϩϩ = feature very marked. 
Ultrastructural Findings. The 11 cases in which we performed electron microscopic examination revealed similar features. The tumor cells were arranged in sheets with numerous intervening cell processes. Seven cases showed neurosecretory granules in cytoplasm, 100 to 200 nm in diameter, and five cases showed microtubules with electronlucent centers that were sparse in the perikaryal cytoplasm and numerous in the cytoplasmic processes. In two cases, well-formed synapses were identified within the neoplasm.
Special Staining for Proliferative Potential. To predict the proliferative potential, immunoreactivity to PCNA, silver colloid staining for AgNORs, and DNA flow cytometry were performed in 10 of 13 cases. On staining with PCNA, all of the tumors expressed less than 1% positive rate. Diploidy was revealed in all cases by DNA flow cytometry with a mean proliferation index of 7.8% (range 5.1%-9.6%). In the one case of recurrence (Case 10), the tumor showed a less than 1% positive rate for PCNA, 1.38 AgNORs score, and diploidy on DNA flow cytometry. The other case (Case 8) with nuclear pleomorphism and mitoses showed a PCNA-positive rate less than 1%, an AgNORs score of 1.67, and diploidy on DNA flow cytometry. The results indicate that central neurocytoma has low proliferative potential even in a recurrent case and a histologically atypical form. The results of immunohistochemical staining for neuronal markers, electron microscopic findings, and proliferative potentials are summarized in Table 2 .
Patient Prognosis
There was a recurrence in two patients (Cases 1 and 10). One patient (Case 1) developed a recurrent tumor 18 months after gross-total removal. Although radiation therapy was prescribed after recurrence, he received only 1400 cGy before refusing further treatment. The other patient (Case 10) developed a recurrent tumor 26 months postoperatively. The patient underwent subtotal removal initially and the postoperative residual mass disappeared after fractionated radiation therapy of 5400 cGy. However, the patient experienced a recurrence and eventually died secondary to tumor progression. The remaining 11 patients are free of recurrent disease at 14 to 109 months (median 50 months) postsurgery. One patient who showed mild nuclear pleomorphism and mitoses (Case 8) is also in good medical condition without evidence of recurrence at 38 months after subtotal removal plus fractionated radiation therapy. The treatment and follow-up results are summarized in Table 3 .
Illustrative Cases
Case 1. This 23-year-old man was admitted to the Department of Neurosurgery at our hospital with a 1-month history of headache. Computerized tomography of the brain showed an intraventricular mass in the right lateral ventricle that extended into the third ventricle. The mass was totally removed via the left frontotranscortical approach on June 6, 1982 . At that time the histological diagnosis was oligodendroglioma. No residual mass was found on postoperative CT scanning. However a recurrent tumor developed 18 months postsurgery. Although radiation therapy was administered after recurrence, the patient received only 1400 cGy before refusing further treatment. The histological diagnosis was revised to central neurocytoma after reexamination with immunohistochemical staining of neuronal markers and electron microscopy in December 1990.
Case 8. This 24-year-old man was admitted to our service with a 3-month history of headache and vomiting. A mass was found in the left lateral ventricle on MR imaging, and cerebral angiography showed vascular staining ( Fig. 2A-C) . The tumor was subtotally removed secondary to profuse intraoperative bleeding. Mild nuclear pleomorphism and mitoses were found on light microscopic examination (Fig. 2D) . Immunohistochemical stainings for neuronal markers and electron microscopic examination were performed and the tumor was diagnosed as an atypical form of central neurocytoma. The patient received 5580 cGy of radiation therapy postoperatively. An MR image obtained 34 months after the operation showed no definite enhancing mass, probably secondary to radiation effect (Fig. 2E) . The patient is in good medical condition and can perform his normal activities. On staining for immunoreactivity to PCNA, the positive cell rate was less than 1% and AgNORs score was 1.67. Flow cytometry revealed a diploidy pattern and the proliferative index was 7.3% ( Fig. 2F and G) .
Discussion
Literature Review
Most authors report that central neurocytomas affect young adults without predilection for either sex. However, in our series there were two 60-year-old patients, and there was a predominance of men. Consequently, central neurocytoma must be considered in the differential diagnoses of anteriorly located lateral ventricular tumors, even in the elderly patient. The reason for the finding of male predominance in our study versus previously reported series is uncertain.
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Central neurocytoma: proliferative potential 745 There are some reports of anaplastic or malignant forms of central neurocytomas that show vascular proliferation, high mitotic rate, and focal necrosis; however, the clinical courses of those cases were not fully evaluated. 19, 21 Recently, Mrak 13 reported two cases of a malignant variant of central neurocytoma with rapid progression to death. One of our cases showed mild nuclear pleomorphism and mitoses on light microscopy. The patient received fractionated radiation therapy of 5580 cGy after subtotal removal of the tumor and is without recurrence in the 38-month follow-up period.
Neuron-specific enolase 3, 5, [9] [10] [11] [12] 17, 19, 20, 22 and synaptophysin 2, 3, 5, 9, 10, 19, 20, 22 are the most frequently used markers in the immunohistochemical diagnosis of central neurocytoma, but NSE is considered to have limited specificity. 8 Synaptophysin, a structural component of the synaptic vesicle membrane, is considered the most reliable marker for the diagnosis of central neurocytoma. 8 Due to technical inadequacies in some series, 2, 5, 9, 11, 12 even synaptophysin was not always found to be expressed in central neurocytoma. Therefore, the lack of synaptophysin or NSE expression does not exclude the diagnosis of central neurocytoma and would additionally require electron microscopy for identification of neuronal differentiation. Other neuronal marker proteins associated with central neurocytoma are neurofilament protein, 19 neuron-associated class III ␤-tubulin, 9 microtubule-associated proteins 2, and tau. 9 In our series, NSE and synaptophysin were positive in all cases. There were two cases that showed focal expression of GFAP, which was thought to be due to entrapped astrocytic cells in the tumor.
Proliferative Potential and Biological Behavior
Limited data reported previously showed that central neurocytomas have low proliferative potential. 2, 3, 6, 22 Casadei, et al., 3 studied immunoreactivity to PCNA in four cases and reported a staining index of less than 1%. Hara, et al., 6 reported silver colloid staining for AgNORs in four cases. Three cases showed an AgNORs score below 2 and D. G. Kim, et al. even in a recurrent case it was 2.06. The studies using Ki-67 showed similar results. 2, 22 However, simultaneous assessment of proliferative potential with PCNA, AgNORs, and DNA flow cytometry in a relatively large series is lacking in the literature. We found that central neurocytoma has low proliferative potential even in a recurrent case, which showed a less than 1% positive cell rate for PCNA, a 1.38 AgNORs score, and diploidy in flow cytometry. One case of a histologically atypical form also showed low proliferative potential and a benign clinical course during a 38-month follow-up period. Central neurocytoma is considered to show a benign clinical course with limited proliferative potential. However, there are four reported cases of recurrence including our two cases and two cases of malignant tumor with rapid progression to death. 6, 13, 19, 21 Central neurocytoma is believed to arise from the neuronal precursors in the periventricular germinal matrix, which persist throughout adult life in the mammalian brain. 5, 9, 11, 19, 20 However, there are several reports of unusual central neurocytomas that had originated from extraventricular areas. Nishio, et al., 15 reported a cerebral hemispheric neurocytoma. Coca, et al., 4 and Tatter, et al., 18 reported a spinal cord neurocytoma. In one of our two recurrent cases, the tumor arose from the posterior thalamus and extended into the lateral ventricle. It recurred after subtotal removal plus fractionated radiation therapy. A few reported cases of neurocytoma in which the tumor is located in a site other than the typical supratentorial intraventricular region suggest that the origin of the tumor is not always the neuronal precursors in the periventricular germinal matrix and that these tumors might have a somewhat different clinical course.
Radiation Therapy
Because central neurocytomas are considered benign tumors with low proliferative potential, radiation therapy is not theoretically necessary. However, there are several reports claiming that postoperative radiation therapy for central neurocytoma leads to the disappearance or shrinkage of residual tumors. 1, 2, 5, 14, 16, 17 In our series, five patients received fractionated radiation therapy following subtotal removal of their tumors and four of those tumors showed shrinkage. The other case showed disappearance of tumor even though the tumor recurred subsequently. Long-term controlled studies are needed for evaluation of postoperative radiation therapy; however, radiation therapy is thought to be necessary for residual or recurrent central neurocytoma.
Conclusions
In conclusion, central neurocytomas are benign supratentorial intraventricular neuronal tumors that have low proliferative potential, but somewhat varying forms with respect to clinical course and growth pattern are also present.
